Pauline Chazelas

Pauline Chazelas

Auto-generated profile, based on publicly available information

Pauline Chazelas

University of Limoges, UR20218 - NeurIT, Limoges F-87000, France; Centre Hospitalo-Universitaire (CHU) Limoges, Biochemistry and Molecular Genetics Department, Limoges F-87000, France

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2022 in Chest
Verified
Journal Article
Closed access
LGLaurent Guilleminault
Laurent Guilleminault
PCPauline Chazelas
Pauline Chazelas
BMBoris Melloni
Boris Melloni
CMCorinne Magdelaine
Corinne Magdelaine
TVThomas Villeneuve
Thomas Villeneuve
LMLaurent Magy
Laurent Magy

1 March 2021 in Experimental Eye Research
Verified
Journal Article
Open access
PFPierre-Antoine FAYE
Pierre-Antoine FAYE
FPFrançois Poumeaud
François Poumeaud
PCPauline Chazelas
Pauline Chazelas
MDMathilde Duchesne
Mathilde Duchesne
MRMarion Rassat
Marion Rassat
YBYohan Benayoun
Yohan Benayoun
The cornea is a multi-layered structure which allows fine refraction and provides both resistance to external insults and adequate transparency. The corneal endothelium ensures stromal hydration, failure of which, such as in Fuchs endothelial corneal dystrophy, after trauma or in aging, may lead to loss of corneal transparency and induce blindness. Currently, no efficient therapeutic alternatives exist except for corneal grafting. Thus corneal tissue engineering represents a valuable alternative approach, which may overcome cornea donor shortage. Several studies describe protocols to isolate, differentiate, and cultivate corneal endothelial cells (CEnCs) in vitro. Two main in vitro strategies can be described: expansion of eye-native cell populations, such as CEnCs, or the production and expansion of CEnCs from non-eye native cell populations, such as induced Pluripotent Stem Cells (iPSCs). The challenge with these cells is to obtain a monolayer of CEnCs on a biocompatible carrier, with a specific morphology (flat hexagonal cells), and with specific functions such as programmed cell cycle arrest. Another issue for this cell culture methodology is to define the adapted protocol (media, trophic factors, timeframe) that can mimic physiological development. Additionally, contamination by other cell types still represents a huge problem. Thus, purification methods, such as Fluorescence Activated Cell Sorting (FACS), Magnetic Ativated Cell Sorting (MACS) or Sedimentation Field Flow Fractionation (SdFFF) are useful. Animal models are also crucial to provide a translational approach for these therapies, integrating macro- and microenvironment influences, systemic hormonal or immune responses, and exogenous interactions. Non-eye native cell graft protocols are constantly improving both in efficacy and safety, with the aim of being the most suitable candidate for corneal therapies in future routine practice. The aim of this work is to review these different aspects with a special focus on issues facing CEnC culture in vitro, and to highlight animal graft models adapted to screen the efficacy of these different protocols.

1 August 2024 in Neurology Genetics
Verified
Journal Article
Closed access
SFSimon Frachet
Simon Frachet
PCPauline Chazelas
Pauline Chazelas
LMLaurent Magy
Laurent Magy
PCPascal Cintas
Pascal Cintas
DBDanielle Brouquières
Danielle Brouquières
ALAnne-Sophie Lia
Anne-Sophie Lia
Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome results from variations in RFC1 and is mostly caused by intronic biallelic pathogenic expansions (RE-RFC1). Refractory chronic cough (RCC) is frequently observed for years to decades preceding ataxia onset. Whether peripheral nerves are involved in the presymptomatic phase characterized by RCC is uncertain. Here, patients previously screened for RCC and identified as having at least one RE-RFC1 intronic expansion underwent a comprehensive clinical and neurophysiologic assessment and were screened for additional exonic variations. Fourteen patients with RCC and RE-RFC1 were investigated. Seven patients presented with biallelic RE-RFC1 (Bi-RE-RFC1) while 7 presented with monoallelic RE-RFC1 (Mono-RE-RFC1). In patients with Mono-RE-RFC1, no additional exonic variation was identified, and clinical examinations were normal. Most of the patients with Bi-RE-RFC1 presented with subtle neurologic impairment, mainly exhibiting decreased lower limb vibration sense (85.7%). Nerve conduction studies revealed that all patients with Bi-RE-RFC1 exhibited lower sensory sum scores than patients with Mono-RE-RFC1 (median 20.2 µV vs 84.9 µV, p = 0.0012). In addition, the radial-to-sural sensory ratios were null or inverted (>0.5) in all patients but one with Bi-RE-RFC1, which is consistent with sensory neuronopathy. Patients with Bi-RE-RFC1 already exhibit widespread sensory neuron involvement at the time of apparently isolated RCC.

10 March 2025 in Clinical Neurophysiology
Verified
Journal Article
Closed access
PFPierre-Antoine FAYE
Pierre-Antoine FAYE
CMC. Magdelaine
C. Magdelaine
CEC. Espil
C. Espil
CLCamille Julia Loret
Camille Julia Loret
CSC. Scherrer
C. Scherrer
LMLaurent Magy
Laurent Magy